Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Gubra: Indkalder til EO generalforsamling

By Claus ThestrupCEO, Sweden
Gubra

Selskabet indkalder til EO generalforsamling den 27. juni 2025 med et emne på agendaen - udbetaling af udbytte. Gubra indgik en aftale med Abbvie på GUBamy tidligere i år. Denne partneraftale indeholder bl.a. en upfront betaling på USD 350 mio. Selskabet ønsker nu at få ejernes accept for udbetaling af en ekstraordinært udbytte på DKK 1.000 mio eller cirka 61,2 DKK/aktie.

Læs hele meddelelsen her: EO generalforsamling

Disclaimer: HC Andersen Capital modtager betaling fra Gubra for en Digital IR abonnementsaftale. Claus Thestrup kl. 08:25, d 03.06.2025.

Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They primarily conduct research and development in the area of metabolic and fibrotic diseases. The company's product portfolio includes several brands and drugs, and the operations are conducted on a global level, with the largest presence in North America and the Nordic region. The headquarters are located in Hørsholm, Denmark.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.